JP2017511368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511368A5 JP2017511368A5 JP2016562898A JP2016562898A JP2017511368A5 JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5 JP 2016562898 A JP2016562898 A JP 2016562898A JP 2016562898 A JP2016562898 A JP 2016562898A JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- grams
- stereoisomer
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 64
- 150000001875 compounds Chemical class 0.000 claims 32
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 claims 31
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 claims 31
- 229960003644 aztreonam Drugs 0.000 claims 31
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 8
- 150000002148 esters Chemical class 0.000 claims 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims 4
- 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims 2
- -1 5-((S) -pyrrolidin-2-yl)-[1,3,4] -oxadiazol-2-yl Chemical group 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- UKXQKDPNYXVESI-RKDXNWHRSA-N N1CC(C1)CC1=NN=C(O1)[C@@H]1N2C(N([C@H](CC1)C2)OS(O)(=O)=O)=O Chemical compound N1CC(C1)CC1=NN=C(O1)[C@@H]1N2C(N([C@H](CC1)C2)OS(O)(=O)=O)=O UKXQKDPNYXVESI-RKDXNWHRSA-N 0.000 claims 2
- IIGJRSBRPZGZLI-RRKCRQDMSA-N [(2R,5R)-2-[5-[(1S)-1-aminoethyl]-1,3,4-oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate Chemical compound N[C@@H](C)C1=NN=C(O1)[C@@H]1N2C(N([C@H](CC1)C2)OS(O)(=O)=O)=O IIGJRSBRPZGZLI-RRKCRQDMSA-N 0.000 claims 2
- JQDYTHSKUVKCRO-PHDIDXHHSA-N [(2R,5R)-2-cyano-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate Chemical compound C1N2[C@@H](C#N)CC[C@@]1([H])N(OS(O)(=O)=O)C2=O JQDYTHSKUVKCRO-PHDIDXHHSA-N 0.000 claims 2
- DQAAOYQVZVPGLQ-AXFHLTTASA-N [(2s,5r)-7-oxo-2-[[(2s)-piperidin-2-yl]methoxycarbamoyl]-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate Chemical compound O=C([C@H]1N2C[C@@H](CC1)N(C2=O)OS(=O)(=O)O)NOC[C@@H]1CCCCN1 DQAAOYQVZVPGLQ-AXFHLTTASA-N 0.000 claims 2
- ZUNVUNFTDRACHR-AEJSXWLSSA-N [(2s,5r)-7-oxo-2-[[(2s)-pyrrolidin-2-yl]methoxycarbamoyl]-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate Chemical compound O=C([C@H]1N2C[C@@](CC1)(N(C2=O)OS(O)(=O)=O)[H])NOC[C@@H]1CCCN1 ZUNVUNFTDRACHR-AEJSXWLSSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1407/MUM/2014 | 2014-04-18 | ||
| IN1407MU2014 | 2014-04-18 | ||
| PCT/IB2015/052814 WO2015159265A1 (en) | 2014-04-18 | 2015-04-17 | Pharmaceutical compositions comprising antibacterial agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511368A JP2017511368A (ja) | 2017-04-20 |
| JP2017511368A5 true JP2017511368A5 (enExample) | 2018-06-07 |
| JP6678116B2 JP6678116B2 (ja) | 2020-04-08 |
Family
ID=53276202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562898A Expired - Fee Related JP6678116B2 (ja) | 2014-04-18 | 2015-04-17 | 抗菌剤を含む医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10857138B2 (enExample) |
| EP (1) | EP3131583A1 (enExample) |
| JP (1) | JP6678116B2 (enExample) |
| KR (1) | KR102173632B1 (enExample) |
| CN (1) | CN107980000A (enExample) |
| BR (1) | BR112016024235A2 (enExample) |
| MX (1) | MX2016013431A (enExample) |
| WO (1) | WO2015159265A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10417727B2 (en) * | 2016-09-26 | 2019-09-17 | Uber Technologies, Inc. | Network system to determine accelerators for selection of a service |
| EP3301094A1 (en) * | 2016-09-30 | 2018-04-04 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
| KR102354697B1 (ko) * | 2017-03-02 | 2022-01-21 | 욱크하르트 리미티드 | 항박테리아 화합물로서의 헤테로고리 유도체 |
| US10085999B1 (en) * | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
| TW201925201A (zh) * | 2017-11-10 | 2019-07-01 | 日商鹽野義製藥股份有限公司 | 二氮雜二環辛烷衍生物 |
| JP7273420B2 (ja) | 2018-01-25 | 2023-05-15 | エボポイント、バイオサイエンシズ、カンパニー、リミテッド | β－ラクタマーゼ阻害剤及びその用途 |
| DK3833665T3 (da) | 2018-08-09 | 2023-10-09 | Antabio Sas | Diazabicyclooctanoner som hæmmere af serin-beta-lactamaser |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| KR20240107154A (ko) | 2021-11-17 | 2024-07-08 | 에보포인트 바이오사이언시스 컴퍼니 리미티드 | β-락타마제 억제제 중간체 및 이의 제조 방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US342553A (en) * | 1886-05-25 | Induction-coil | ||
| US2874279A (en) | 1952-08-06 | 1959-02-17 | Itt | Pulse selector circuit |
| RU2636147C1 (ru) * | 2011-08-27 | 2017-11-21 | Вокхардт Лимитед | Производные 1,6-диазабицикло[3,2,1]октан-7-она и их применение при лечении бактериальных инфекционных болезней |
| AU2012303693B2 (en) * | 2011-08-30 | 2014-07-03 | Wockhardt Limited | 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections |
| US8754102B2 (en) | 2011-09-13 | 2014-06-17 | Wockhardt Ltd. | Nitrogen containing compounds and their use |
| US8796257B2 (en) * | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| WO2013149121A1 (en) * | 2012-03-30 | 2013-10-03 | Cubist Pharmaceuticals, Inc. | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
| US8916709B2 (en) * | 2012-03-30 | 2014-12-23 | Cubist Pharmaceuticals, Inc. | 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors |
| TWI565707B (zh) | 2012-05-30 | 2017-01-11 | 明治製菓藥業股份有限公司 | 新穎β－內醯胺酶抑制劑及其製造方法 |
| JP6480870B2 (ja) * | 2013-01-14 | 2019-03-13 | ウォックハート リミテッド | 細菌感染を処置するための組成物および方法 |
-
2015
- 2015-04-17 WO PCT/IB2015/052814 patent/WO2015159265A1/en not_active Ceased
- 2015-04-17 BR BR112016024235A patent/BR112016024235A2/pt not_active Application Discontinuation
- 2015-04-17 CN CN201580020069.3A patent/CN107980000A/zh active Pending
- 2015-04-17 EP EP15726322.9A patent/EP3131583A1/en not_active Withdrawn
- 2015-04-17 JP JP2016562898A patent/JP6678116B2/ja not_active Expired - Fee Related
- 2015-04-17 MX MX2016013431A patent/MX2016013431A/es unknown
- 2015-04-17 US US15/304,486 patent/US10857138B2/en not_active Expired - Fee Related
- 2015-04-17 KR KR1020167031647A patent/KR102173632B1/ko not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017511368A5 (enExample) | ||
| JP2009534386A5 (enExample) | ||
| JP2012533546A5 (enExample) | ||
| RU2015101102A (ru) | Гетероароматическое метильное производное циклического амина | |
| CN105919998B (zh) | 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 | |
| JP2019526596A5 (enExample) | ||
| JP2018528244A5 (enExample) | ||
| JP2012513416A5 (enExample) | ||
| SI3018132T1 (en) | Condensed imidazole derivatives useful as IDO inhibitors | |
| JP2010524932A5 (enExample) | ||
| JP2017505293A5 (enExample) | ||
| JP2012532136A5 (enExample) | ||
| JP2015501833A5 (enExample) | ||
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| JP2016534148A5 (enExample) | ||
| JP2019510794A5 (enExample) | ||
| JP2018502906A5 (enExample) | ||
| JP2014534981A5 (enExample) | ||
| JP2014509600A5 (enExample) | ||
| JP2014510147A5 (enExample) | ||
| JP2011509301A5 (enExample) | ||
| JP2010132677A5 (enExample) | ||
| JP2016540811A5 (enExample) | ||
| JP2013537240A5 (enExample) | ||
| JP2014532754A5 (enExample) |